Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from "assessment of Pexelizumab in Acute Myocardial Infarction"

American Heart Journal

Volumn 162, Issue 1, 2011, Pages 89-97

  French, John K ^a   Armstrong, Paul W ^b   Cohen, Eric ^c   Kleiman, Neal S ^d   O'Connor, Christopher M ^e   Hellkamp, Anne S ^e   Stebbins, Amanda ^e   Holmes, David R ^f   Hochman, Judith S ^g   Granger, Christopher B ^e   Mahaffey, Kenneth W ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF ALBERTA   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f MAYO CLINIC   (United States)

^g NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; INTERLEUKIN 6; PEXELIZUMAB; PLACEBO; TROPONIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; ANGINA PECTORIS; ARTICLE; BLOOD CLOT LYSIS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOGENIC SHOCK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART RATE; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVOR; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SINGLE-CHAIN ANTIBODIES; SURVIVAL RATE; WORLD HEALTH;

EID: 79960163345     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.04.009     Document Type: Article

References (25)

1. D. Hasdai, E.J. Topol, and R. Kilaru Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials Am Heart J 145 2003 73 79 (Pubitemid 36034500)
2. R.J. Goldberg, N.A. Samad, and J. Yarzebski Temporal trends in cardiogenic shock complicating acute myocardial infarction N Engl J Med 340 1999 1162 1168 (Pubitemid 29177875)
3. J.K. French, B.F. Williams, and H.H. Hart Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction Br Med J 312 1996 1637 1641 (Pubitemid 26229451)
4. K.A.A. Fox, P.G. Steg, and K.A. Eagle Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900 (Pubitemid 46707843)
5. J. Fang, G.A. Mensah, and M.H. Alderman Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States Am Heart J 152 2006 1035 1041 (Pubitemid 44854794)
6. R.G. Goldberg, F.A. Spencer, and J.M. Gore Thirty-year trends (1975-2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction. A population-based perspective Circulation 119 2009 1211 1219
7. J.S. Hochman, L.A. Sleeper, and H.D. White One-year survival following early revascularization for cardiogenic shock JAMA 285 2001 190 192 (Pubitemid 32048521)
8. A. Babaev, P.D. Frederick, D.J. Pasta for the MRMI investigators Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock JAMA 294 2005 448 454 (Pubitemid 41124177)
9. H.W. Audrey, L. Parsons, and N.R. Every Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction. A report from the Second National Registry of Myocardial Infarction (NRMI-2) J Am Coll Cardiol 40 2002 1389 1394 (Pubitemid 35192861)
10. P.G. Steg, O.H. Dabbous, L.J. Feldman for the Global Registry of Acute Coronary Events (GRACE) Investigators Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE) Circulation 109 2004 494 499 (Pubitemid 38168512)
11. A. Kashani, R.P. Giugliano, and E.M.A. Antman Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction Eur Heart J 25 2004 1702 1710 (Pubitemid 39286635)
12. The APEX AMI Investigators Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial JAMA 297 2007 43 51
13. K.W. Mahaffey, J.L. Wampole, A. Stebbins for the APEX-AMI investigators Efficient adjudication of endpoints in an international trial: strategic lessons from the Clinical Events Committee of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Circulation 116 2007 II-317
14. A. Stebbins, R.H. Mehta, P.W. Armstrong for the APEX-AMI investigators A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Circ Cardiovasc Interv 3 2010 414 422
15. P.G. Steg, E. Bonnefoy, S. Chabaud for the Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty data from the CAPTIM randomized clinical trial Circulation 108 2003 2851 2856 (Pubitemid 37517811)
16. S. Carstensen, G.C.I. Nelson, and P.S. Hansen Field triage to prima angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome Eur Heart J 28 2007 2313 2319 (Pubitemid 47537780)
17. R.V. Jeger, D. Radovanovic, P.R. Hunziker for the AMIS Plus Registry Investigators Ten-tear trends in the incidence and treatment of cardiogenic shock Ann Intern Med 149 2008 618 626
18. C.B. Granger, K.W. Mahaffey, and W.D. Weaver Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial Circulation 108 2003 1184 1190 (Pubitemid 37099985)
19. The TRIUMPH Investigators Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock the TRIUMPH randomized controlled trial J Am Med Assoc 297 2007 1657 1666
20. S.J. Nicholls, Z.N. Wang, and R. Koeth Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction Circulation 116 2007 2315 2324 (Pubitemid 350100338)
21. S.R. Dixon, R.J. Whitbourn, and M.W. Dae Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction J Am Coll Cardiol 40 2002 1928 1934 (Pubitemid 35425362)
22. G.W. Stone, S.R. Dixon, and C.L. Grines Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials Am J Cardiol 100 2007 1370 1375 (Pubitemid 47592901)
23. T. Svilaas, P.J. Vlaar, and I.C. van der Horst Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567 (Pubitemid 351214283)
24. D. Rott, S. Nehar, and J. Leor Effect on survival of acute myocardial infarction in Killip class II or III patients undergoing invasive coronary procedures Am J Cardiol 88 2001 618 623 (Pubitemid 32831093)
25. H. Thiele, B. Allam, and G. Chatellier Shock in acute myocardial infarction: the Cape Horn for trials? Eur heart J 31 2010 1828 1835